ArticleBMC cancer2024

Node-sparing modified short-course Radiotherapy Combined with CAPOX and Tislelizumab for locally Advanced MSS of Middle and low rectal Cancer (mRCAT): an open-label, single-arm, prospective, multicentre clinical trial.

Cheng Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.